X0508 4 2026-02-24 0000887359 Vericel Corp VCEL 0001778858 Halpin Michael 64 SIDNEY STREET CAMBRIDGE MA 02139 true Chief Operating Officer false Common Stock 2026-02-24 4 M 0 5250 0 A 26107 D Common Stock 2026-02-24 4 F 0 2486 38.09 D 23621 D Common Stock 2026-02-24 4 M 0 5250 0 A 28871 D Common Stock 2026-02-24 4 F 0 2486 38.25 D 26385 D Restricted Stock Unit 2026-02-24 4 M 0 5250 A Common Stock 5250 15750 D Restricted Stock Unit 2026-02-24 4 M 0 5250 A Common Stock 5250 10500 D The shares of common stock were acquired by the Reporting Person as a result of the vesting of Restricted Stock Units (RSUs) granted to the Reporting Person on February 20, 2025. The remaining RSUs will vest in annual installments on February 20, 2027, February 20, 2028, and February 20, 2029, respectively. These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). These shares were withheld by the Issuer to satisfy the tax withholding requirements in connection with the vesting of RSUs. The shares of common stock were acquired by the Reporting Person as a result of the vesting of RSUs granted to the Reporting Person on February 22, 2024. The remaining RSUs will vest in annual installments on February 22, 2027, and February 22, 2028, respectively. Each RSU represents a contingent right to receive one share of common stock of Vericel Corporation. No expiration date for this type of award. The Fair Market Value of the vested derivative securities is $38.09 per share. The Fair Market Value of the vested derivative securities is $38.25 per share. /s/ Sean Flynn, as Attorney-in-Fact for Michael Halpin 2026-02-26